Physician profile
Jorge Montalvan
NPI 1679554596
$10,183.04
in general payments reported to CMS, 2019-2025
55 companies · $1,455 in 2025
The $1,455 reported for 2025 was more than what 90% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,416 · 2020: $1,356 · 2021: $2,417 · 2022: $407 · 2023: $1,444 · 2024: $1,688 · 2025: $1,455.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,586 · Education: $1.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,585.61 |
| Education | $1.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,148.48 | 2019-2025 | Repatha, Otezla, Evenity |
| Abbvie INC. | $897.99 | 2020-2025 | |
| Astrazeneca Pharmaceuticals Lp | $843.03 | 2019-2025 | Breztri, Airsupra, Wainua |
| Janssen Pharmaceuticals, INC | $811.57 | 2019-2023 | Spravato |
| Glaxosmithkline, LLC. | $648.83 | 2019-2023 | Shingrix, Arexvy |
| Amarin Pharma, INC. | $624.65 | 2019-2021 | |
| Edwards Lifesciences Corporation | $572.27 | 2024-2025 | |
| Pfizer INC. | $437.32 | 2019-2025 | |
| Astellas Pharma US INC | $327.41 | 2019-2025 | Veozah |
| Exact Sciences Corporation | $327.14 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Lilly USA, LLC | $297.49 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Biohaven Pharmaceuticals, INC. | $240.81 | 2021 | |
| Kvk-Tech, INC. | $231.90 | 2019-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $209.60 | 2019 | |
| Cleerly, INC. | $170.90 | 2025 | Cleerly Ischemia, Cleerly Labs |
Show all 55 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $144.30 | 2025 | Indigo System |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $126.53 | 2019-2025 | Xifaxan |
| Daiichi Sankyo INC. | $124.94 | 2021 | |
| Novo Nordisk INC | $123.10 | 2023-2025 | Rybelsus, Ozempic, Wegovy |
| Sumitomo Pharma America, INC. | $122.41 | 2023-2025 | Gemtesa |
| Biohaven Pharmaceutical Holding Company Ltd. | $120.85 | 2022 | |
| Medtronic Vascular, INC. | $119.88 | 2020 | |
| Medtronic, INC. | $114.20 | 2022 | |
| Novartis Pharmaceuticals Corporation | $110.70 | 2020-2024 | |
| Radius Health, INC. | $104.39 | 2019-2025 | Tymlos |
| Allergan, INC. | $91.96 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $91.82 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $90.43 | 2019-2023 | Livalo |
| Eisai INC. | $63.23 | 2021-2024 | |
| Mylan Specialty L.P. | $61.54 | 2020 | |
| Philips North America LLC | $58.37 | 2019 | |
| Merck Sharp & Dohme LLC | $49.02 | 2019-2025 | Capvaxive, Gardasil 9 |
| Biogen, INC. | $48.92 | 2021 | |
| Phadia US INC. | $48.14 | 2023-2024 | Immunocap |
| Boston Scientific Corporation | $45.17 | 2023-2025 | Watchman Flx, Watchman Access System |
| Saluda Medical Americas, INC. | $44.02 | 2025 | Evoke |
| Idorsia Pharmaceuticals US INC | $43.55 | 2023 | Quviviq |
| Corcept Therapeutics | $43.53 | 2024 | Korlym |
| Lundbeck LLC | $42.81 | 2023-2025 | Rexulti |
| Medicure Pharma INC. | $34.40 | 2021-2025 | Zypitamag |
| Almatica Pharma LLC | $33.55 | 2023 | Loreev Xr, Gralise, Sertraline Hcl |
| Hologic Sales and Service, LLC | $30.39 | 2019-2023 | Thinprep 2000 Processor, Aptima |
| Seqirus USA INC | $30.09 | 2019-2025 | Flucelvax, Fluad |
| Phathom Pharmaceuticals, INC. | $28.92 | 2024 | Voquezna |
| Takeda Pharmaceuticals U.S.A., INC. | $26.06 | 2025 | Vpriv |
| Esperion Therapeutics, INC. | $22.11 | 2024 | Nexletol |
| Cvrx, INC. | $21.39 | 2025 | Barostim Neo System |
| Shield Therapeutics INC | $19.97 | 2024 | |
| Integra Lifesciences Corporation | $18.87 | 2020 | |
| Roche Diagnostics Corporation | $18.00 | 2020 | |
| Gilead Sciences, INC. | $16.55 | 2020 | |
| Abbott Laboratories | $15.92 | 2019 | |
| Sunovion Pharmaceuticals INC. | $15.70 | 2019 | |
| Axonics, INC. | $14.98 | 2024 | Axonics |
| Vivus LLC | $12.94 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jorge Montalvan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.